>
Will Trump End Sham Democracy Promotions?
Review: Thumb-sized thermal camera turns your phone into a smart tool
Americans stranded in Jamaica plea for help as 'worst ever hurricane' to slam Caribbean isla
Urgent warning to Gmail users as 183 MILLION passwords are stolen in data breach...
Graphene Dream Becomes a Reality as Miracle Material Enters Production for Better Chips, Batteries
Virtual Fencing May Allow Thousands More Cattle to Be Ranched on Land Rather Than in Barns
Prominent Personalities Sign Letter Seeking Ban On 'Development Of Superintelligence'
Why 'Mirror Life' Is Causing Some Genetic Scientists To Freak Out
Retina e-paper promises screens 'visually indistinguishable from reality'
Scientists baffled as interstellar visitor appears to reverse thrust before vanishing behind the sun
Future of Satellite of Direct to Cellphone
Amazon goes nuclear with new modular reactor plant
China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them

Yale scientists have now discovered a molecule that can be given to quickly boost their numbers back up, to help fight off infections without antibiotics.
Neutrophils are a type of white blood cell that are among the first responders to foreign threats like bacteria, viruses or fungi. Unfortunately, their levels can drop in a condition called neutropenia, which can be the result of certain genetic conditions or a side effect of a treatments like chemotherapy. In either case, the low neutrophil counts can make infections more serious, and there are few options for boosting them.
In the new study, Yale scientists have identified a molecule that may help. Officially known as A485, and unofficially as "prohiberin," the molecule blocks certain proteins that regulate gene expression, triggering the release of neutrophils and other white blood cells from bone marrow.
In tests in mice, A485 was found to work quickly and only temporarily, with white blood cell counts dropping back to normal by the 12-hour mark. That might sound like a disadvantage, but it's actually a good thing, the team says.
"Currently, the main treatment for low white blood cell counts is G-CSF, or granulocyte colony stimulating factor, which is produced by the body and can be administered as a drug," said Nikolai Jaschke, lead author of the study. "But it has a long-lasting effect, which can be harmful in some circumstances, limiting its wider clinical use. A485 is just as potent as G-CSF but less enduring."